Lucas Wiessing (PhD) is an epidemiologist and principal scientist at the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) in Lisbon.
He co-ordinates international studies on drug use and drug related consequences and interventions in the European Union – including on HIV and hepatitis C in injecting drug users, drug treatment and harm reduction.
He is a national from the Netherlands, has published frequently and collaborates with many relevant organisations and experts in his field, including participation in key international expert and advisory groups and scientific conferences.
